BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
0.432
-0.021 (-4.55%)
Nov 7, 2024, 1:27 PM EST - Market open

BioLineRx Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
17.054.8----
Upgrade
Cost of Revenue
6.043.69----
Upgrade
Gross Profit
111.11----
Upgrade
Selling, General & Admin
35.2731.5811.535.314.754.67
Upgrade
Research & Development
10.5512.5217.6319.4718.1723.44
Upgrade
Operating Expenses
45.8244.129.1624.7822.9328.11
Upgrade
Operating Income
-34.82-42.99-29.16-24.78-22.93-28.11
Upgrade
Interest Expense
-2.89-2.14-1.79-0.98-1.47-2.25
Upgrade
Interest & Investment Income
2.132.010.690.280.240.78
Upgrade
Currency Exchange Gain (Loss)
0.060.06-0.350.28-0.14-
Upgrade
Other Non Operating Income (Expenses)
12.1-10.845.64-1.85-5.724.14
Upgrade
EBT Excluding Unusual Items
-23.42-53.91-24.95-27.05-30.02-25.45
Upgrade
Asset Writedown
-6.7-6.7----
Upgrade
Pretax Income
-30.12-60.61-24.95-27.05-30.02-25.45
Upgrade
Net Income
-30.12-60.61-24.95-27.05-30.02-25.45
Upgrade
Net Income to Common
-30.12-60.61-24.95-27.05-30.02-25.45
Upgrade
Shares Outstanding (Basic)
1,073963774663253146
Upgrade
Shares Outstanding (Diluted)
1,073963774663253146
Upgrade
Shares Change (YoY)
22.24%24.47%16.75%162.19%72.70%34.82%
Upgrade
EPS (Basic)
-0.03-0.06-0.03-0.04-0.12-0.17
Upgrade
EPS (Diluted)
-0.03-0.06-0.03-0.04-0.12-0.17
Upgrade
Free Cash Flow
-30.42-22.72-26.37-23.67-23.21-22.73
Upgrade
Free Cash Flow Per Share
-0.03-0.02-0.03-0.04-0.09-0.16
Upgrade
Gross Margin
64.55%23.08%----
Upgrade
Operating Margin
-204.22%-895.65%----
Upgrade
Profit Margin
-176.67%-1262.79%----
Upgrade
Free Cash Flow Margin
-178.46%-473.42%----
Upgrade
EBITDA
-33.08-42.17-28.5-24.07-21.99-27.17
Upgrade
D&A For EBITDA
1.740.820.650.70.930.94
Upgrade
EBIT
-34.82-42.99-29.16-24.78-22.93-28.11
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.